SEC ownership of Vicapsys Life Sciences, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001468639.

Comparable stake leader

Wildcat Capital Management, LLC

Disclosed value leader

Wildcat Capital Management, LLC

Comparable rows

1/1

Latest evidence

20 Apr 2020

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
1 of 1
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Wildcat Capital Management, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
20 Apr 2020
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001468639
Issuer location
Cumming, GA

Ownership snapshot

Top shareholders of Vicapsys Life Sciences, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Wildcat Capital Managemen...
Disclosed value leader
Wildcat Capital Managemen...
Comparable rows
1/1
Latest evidence
20 Apr 2020
13D/G 3/4/5 Lead comparable stake: 19% 13D/G row: Wildcat Capital Management, LLC

Quick read

Wildcat Capital Management, LLC leads the comparable SEC ownership view at 19%.

1 of 1 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Wildcat Capital Management, LLC's linked filing trail.
Comparable ownership Top 1
Wildcat Capital Management, LLC 19%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-1 of 1 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Wildcat Capital Management, LLC
13D/G 3/4/5
10%+ Owner
19%
$30,352,940
6,070,588 shares
$0 20 Apr 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 17 Jun 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-1 of 1 reporting-owner rows connected to Vicapsys Life Sciences, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
1
Largest Forms 3/4/5 holder
Wildcat Capital Management, LLC
Net 12M change
$0
Latest report
20 Apr 2020
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Wildcat Capital Management, LLC 10%+ Owner Mixed 20 Apr 2020

Recent insider transactions for Vicapsys Life Sciences, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .